We are live on
!
Find out more
Stifel Financial Portfolio holdings
AUM
$109B
1-Year Est. Return
21.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.33%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+351.88%
AUM
$66.6B
AUM Growth
+$5.55B
(+9.1%)
Cap. Flow
+$370M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
3,449
New
177
Increased
1,464
Reduced
1,530
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$362M |
| 2 |
Tractor Supply
TSCO
|
+$274M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.7M |
| 4 |
Biohaven
BHVN
|
+$79.4M |
| 5 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$464M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$363M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$59.5M |
| 4 |
Duke Energy
DUK
|
+$58.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.39% |
| 2 | Healthcare | 12.41% |
| 3 | Industrials | 9.84% |
| 4 | Consumer Staples | 9.52% |
| 5 | Financials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
FS KKR Capital
FSK
$3.33B
| $789K | ﹤0.01% |
45,113
+10,565
| +31% | +$196K |
|
2177
Sabra Healthcare REIT
SBRA
$5.34B
| $787K | ﹤0.01% |
63,306
-634,654
| -91% | -$8.09M |
|
2178
Nuveen Select Tax-Free Income Portfolio
NXP
$895M
| $785K | ﹤0.01% |
56,462
+157
| +0.3% | +$2.1K |
|
2179
10x Genomics
TXG
$5.79B
| $784K | ﹤0.01% |
21,528
+3,996
| +23% | +$131K |
|
2180
Saia
SAIA
$9.65B
| $782K | ﹤0.01% |
3,732
-815
| -18% | -$178K |
|
|
PENG
2181
Penguin Solutions Inc
PENG
$2.88B
| $780K | ﹤0.01% |
52,426
+5,002
| +11% | +$76.5K |
|
2182
Regenxbio
RGNX
$722M
| $778K | ﹤0.01% |
34,295
+6,497
| +23% | +$147K |
|
|
KRTX
2183
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $778K | ﹤0.01% |
3,957
+991
| +33% | +$213K |
|
2184
Sunrun
RUN
$2.24B
| $777K | ﹤0.01% |
32,352
+3,819
| +13% | +$102K |
|
2185
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $777K | ﹤0.01% |
34,697
+19,503
| +128% | +$433K |
|
2186
Insight Enterprises
NSIT
$4.51B
| $776K | ﹤0.01% |
7,737
-443
| -5% | -$42.3K |
|
2187
Fidelity MSCI Utilities Index ETF
FUTY
$2.28B
| $775K | ﹤0.01% |
16,991
+4,421
| +35% | +$195K |
|
|
ACCD
2188
DELISTED
Accolade Inc
ACCD
| $773K | ﹤0.01% |
99,236
+7,275
| +8% | +$69.5K |
|
2189
New York Times
NYT
$10.5B
| $773K | ﹤0.01% |
23,809
-1,947
| -8% | -$63.5K |
|
|
AGR
2190
DELISTED
Avangrid, Inc.
AGR
| $772K | ﹤0.01% |
17,959
-3,219
| -15% | -$133K |
|
|
PFL
2191
PIMCO Income Strategy Fund
PFL
$388M
| $772K | ﹤0.01% |
95,163
+67,388
| +243% | +$558K |
|
2192
James River Group Holdings
JRVR
$221M
| $769K | ﹤0.01% |
36,792
+6,898
| +23% | +$158K |
|
2193
Nuveen Core Plus Impact Fund
NPCT
$281M
| $768K | ﹤0.01% |
74,122
-12,523
| -14% | -$131K |
|
|
SQZ
2194
DELISTED
SQZ Biotechnologies Company
SQZ
| $766K | ﹤0.01% |
1,035,558
+545,352
| +111% | +$1.19M |
|
2195
Paylocity
PCTY
$8.39B
| $766K | ﹤0.01% |
3,944
-1,917
| -33% | -$412K |
|
2196
Meritage Homes
MTH
$4.71B
| $766K | ﹤0.01% |
16,618
+874
| +6% | +$35.3K |
|
2197
Century Communities
CCS
$1.96B
| $766K | ﹤0.01% |
15,307
-11
| -0.1% | -$520 |
|
2198
Medpace
MEDP
$16.3B
| $766K | ﹤0.01% |
3,604
-632
| -15% | -$126K |
|
2199
Arcosa
ACA
$7.12B
| $765K | ﹤0.01% |
14,061
-1,497
| -10% | -$88.9K |
|
2200
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.07B
| $764K | ﹤0.01% |
8,202
-3,848
| -32% | -$365K |
|
Similar funds
VAM
Stifel Financial's Q4 2022 Portfolio in Review
As of Q4 2022, Stifel Financial held 3,449 positions worth $66.6B, up 9.1% from $61.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Stifel Financial's Q4 2022 filing shows 177 new, 1,464 increased, 1,530 reduced and 165 closed positions. Its largest new stake was Biohaven: 5,619,760 shares worth $78M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $464M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
- Stifel Financial's largest Q4 2022 buy was Biohaven: 5,619,760 shares worth $78M.
- Stifel Financial added most to iShares US Treasury Bond ETF in Q4 2022, an estimated $362M increase.
- Stifel Financial's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $363M.
- Stifel Financial fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $464M.
- Stifel Financial's ten largest holdings make up 15% of its $66.6B portfolio in Q4 2022.
- Stifel Financial opened 177 new positions and closed 165 in Q4 2022.
- Stifel Financial's portfolio value rose 9.1% quarter-over-quarter to $66.6B.
Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.